EPISODE · Jan 28, 2025 · 15 MIN
30 Day FDA and ICH Drug Development Regulations - Day 2 FDA Overview
from Cannabinoid and Psychedelic Pharmacology and Drug Development
In today’s episode, we continue our exploration into the intricate world of drug development, this time focusing on the pivotal role of the U.S. Food and Drug Administration (FDA). From preclinical research to post-market surveillance, we unpack how the FDA safeguards public health at every stage of a drug’s journey—from the lab to your medicine cabinet. Join us as we dive into: - The FDA’s mission and structure - Key regulatory pathways like INDs (Investigational New Drug Applications) and NDAs (New Drug Applications) - The agency's oversight of dietary supplements, cosmetics, and even food additives - The ongoing monitoring of drug safety through tools like PBRERs (Periodic Benefit-Risk Evaluation Reports) - How the FDA adapts to emerging technologies like artificial intelligence and personalized medicine Through analogies, insights, and fascinating facts, this episode highlights the meticulous processes behind the medications we rely on daily. Gain a new appreciation for the FDA's unseen but essential role in ensuring safety, efficacy, and quality across the complex and ever-evolving landscape of healthcare. Takeaway Thought: Next time you take a medication, remember the vast network of science, regulation, and oversight behind it, all driven by the FDA’s unwavering commitment to public health. Stay curious and keep exploring!
NOW PLAYING
30 Day FDA and ICH Drug Development Regulations - Day 2 FDA Overview
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.